GLP-1 Weight Loss in Washington (2026)
42 GLP-1 telehealth providers ship to Washington, District of Columbia. Compounded semaglutide averages $199/month — same active ingredient as Wegovy and Ozempic, a fraction of the cost.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Featured Partners · Washington
Featured GLP-1 providers serving Washington
No insurance needed
reader-supported
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
- Top pick7.6Get started →Save $1,099.01/mo vs Wegovy
Compounded from
$249.99/mo
- 7.3Get started →Save $1,170/mo vs Wegovy
Compounded from
$179/mo
- 7.2Get started →Save $1,150/mo vs Wegovy
Compounded from
$199/mo
| Provider | Compounded from | Save vs brand | |
|---|---|---|---|
7.6MaximusTop pick | $249.99/mo | Save $1,099.01/mo | Get started → |
7.3MEDGm | $179/mo | Save $1,170/mo | Get started → |
7.2HumeCare+ | $199/mo | Save $1,150/mo | Get started → |
Washington at a Glance
About GLP-1 Access in Washington
Washington is a major city in the United States, located in District of Columbia with a population of approximately 712,816. Telehealth is legal in District of Columbia, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Washington ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.
The greater Washington metro area is home to roughly 6,380,000 residents — one of the larger telehealth markets in District of Columbia, even though the city proper is smaller.
District of Columbia's adult obesity rate is approximately 24.7% based on CDC Behavioral Risk Factor Surveillance System data[2], and state rankings are published in CDC's Adult Obesity Facts[3]. Obesity prevalence and telehealth access patterns vary by state; check the District of Columbia provider list above for local availability. Before starting treatment, it's worth understanding what the clinical trials actually showed about GLP-1 side effects.
District of Columbia Medicaid does not currently cover GLP-1s for weight loss alone (diabetes-only coverage), which is why cash-pay compounded semaglutide or tirzepatide — averaging $199/month — is the realistic path for most Washington residents seeking obesity treatment outside a type 2 diabetes diagnosis.
Looking beyond Washington? See all GLP-1 providers in District of Columbia.
Browse by Medication
All GLP-1 Providers Serving Washington
Vytora Health
Best for: compounded or brand-name GLP-1 with named pharmacy partners, 50 states
Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides. It names its pharmacy partners publicly — Vials Pharmacy and Greenwich Biosciences — and discloses its operating physician group, uncommon transparency for the category. Compounded semaglutide runs $180/mo ($150 on a 3-month bundle) and tirzepatide $249/mo ($200 bundled).
Score Breakdown
Pros
- ✓All 50 states plus DC, with per-state video-vs-audio compliance disclosed
- ✓Both compounded and brand-name options on one platform — uncommon
- ✓LegitScript Approved and HIPAA compliant
- ✓Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
- ✓Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)
- ✓Competitive monthly pricing ($180 sema / $249 tirz) plus a 3-month bundle saving 17%
- ✓Brand-name Mounjaro and Zepbound available at $1,399/mo for FDA-approved options
Cons
- ✗Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
- ✗Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
- ✗Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
- ✗Initial consultation cost not shown on the public pricing page
- ✗Limited per-prescriber state licensure detail
EverSlim
Best for: flat-price compounded glp-1 care shipped nationwide
EverSlim is a US telehealth program offering doctor-prescribed, compounded GLP-1 weight-loss medication delivered to your door. It provides compounded semaglutide from 127 dollars a month and compounded tirzepatide from 183 dollars a month, a flat monthly price that includes the provider visit, prescription, and free shipping, with no insurance or membership required. Care is delivered by licensed US providers through the DrTelx medical group and filled by named LegitScript-approved US compounding pharmacies. Available in all 50 states and DC. Compounded meds are not FDA-approved.
Score Breakdown
Pros
- ✓Flat pricing from 127 dollars a month for compounded semaglutide; medication, provider visit, and shipping included, no insurance needed
- ✓Names its pharmacy partners (EPIQ Scripts, Foothills, Emerald) and DrTelx medical group; LegitScript-approved and NABP-accredited.
- ✓Available in all 50 states and DC, with asynchronous care in 44 states and live-visit access in the rest.
- ✓Offers both semaglutide and tirzepatide, plus care-team messaging between visits.
Cons
- ✗Compounded medications are not FDA-approved, and no brand-name Wegovy, Ozempic, or Zepbound options are offered.
- ✗Site discloses that some imagery and content may be AI-generated and some ad figures are actors, not real clinicians.
- ✗Newer brand with limited independent, third-party review history.
Elara Health and Wellness
Best for: bundled-care GLP-1 with labs and coaching from four named pharmacies
Elara Health and Wellness is a physician-guided weight-loss platform offering compounded semaglutide and tirzepatide injections across all 50 states plus DC. Its differentiator is a bundled care-team model — pricing includes medication, quarterly labs, physician visits, coaching, and 24/7 messaging, with four named 503A pharmacy partners disclosed. Semaglutide is $183/mo and tirzepatide $267/mo, with annual plans cutting cost further.
Score Breakdown
Pros
- ✓Corporate parent disclosed (JTE Medical, LLC) — rare transparency for a DTC GLP-1 platform
- ✓Four named 503A pharmacy partners with city/state — among the most pharmacy-transparent providers we've reviewed
- ✓Bundled care model: quarterly labs, physician visits, coaching, and 24/7 messaging without a membership fee
- ✓Publishes the FDA compounded-medication disclaimer
- ✓All 50 states plus DC, with explicit coverage language
- ✓Substantial annual-plan savings ($792/yr semaglutide, $858/yr tirzepatide)
- ✓Self-service cancellation on monthly and quarterly plans
Cons
- ✗LegitScript certification status not disclosed
- ✗No named medical director or physician leadership
- ✗Annual plan requires a 12-month commitment; early-cancellation terms not detailed
- ✗Governing law / arbitration venue not disclosed
- ✗503A patient-specific compounding only — no 503B option
LillyDirect Foundayo
Best for: the cheapest legal brand-name GLP-1
Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss. With the Lilly Savings Card, commercially insured patients pay $25/month; cash-pay patients pay $149-$299/month depending on labeled dose. Requires a valid US prescription from any licensed prescriber.
Score Breakdown
Pros
- ✓Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
- ✓Direct from manufacturer — no compounding, no third-party reseller
- ✓Daily oral pill, no injections, no refrigeration
- ✓Available in all 50 states
Cons
- ✗Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
- ✗Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
- ✗$25 savings card requires commercial insurance — Medicare and Medicaid not eligible
- ✗Strict empty-stomach 30-minute window may be hard for some patients to follow
Pallas Health
Best for: the most complete public disclosure of pharmacies and prescribing physicians we have found
Pallas Health is a telehealth platform operated by Brentmoor, Inc. offering compounded semaglutide and tirzepatide alongside brand-name Wegovy, Ozempic, Zepbound and Mounjaro. Compounded plans average $199 and $299 a month with provider care, check-ins and messaging included and no separate membership fee, and the price stays the same at every dose. Its clinical disclosures page is unusually complete: two named advising physicians with verifiable NPIs, the clinical partner Lion MD, six named partner pharmacies, and coverage in all 50 states plus DC.
Score Breakdown
Pros
- ✓Names six partner pharmacies with phone numbers and websites, the most complete pharmacy disclosure we have recorded.
- ✓Publishes two advising physicians with NPI numbers you can look up yourself in the federal NPPES lookup.
- ✓Price stays the same at every dose, and provider care, check-ins and messaging are included with no membership fee.
- ✓Offers brand-name Wegovy, Ozempic, Zepbound and Mounjaro alongside compounded options, and serves all 50 states plus DC.
Cons
- ✗Billed $597 every 12 weeks, not monthly; at 4.33 cycles a year the true cost is about $216/mo, above the $199 advertised.
- ✗The homepage claims "200,000+ patients" while the clinical page describes a July 2026 launch and existing waitlist patients.
- ✗The current cycle is not prorated or refunded once a clinician has issued the prescription.
- ✗A live video visit is required in Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia and D.C.
Browse all 42 GLP-1 providers serving Washington A–Z
- Andrew Meds
- Apex MD
- Aspen
- Big Easy Weight Loss
- Brello Health
- Care Clinics
- Edessa
- Elara Health and Wellness
- eMI Aesthetics
- EverSlim
- FitRx
- FMmeds
- Fresh Day Meds
- Gatlan
- Gimme Care
- Harmony Wellness Clinic
- He & She MD
- HumeCare+
- InstaRX
- LillyDirect Foundayo
- Luma Health Co
- Magnolia Regenerative Medicine
- Maximus
- MEDGm
- Mixx Health & Wellness
- NP2GO
- OlleveCare
- Ondra Health
- Pallas Health
- Pillar Health
- Primary Clinic (Direct GLP)
- Recovery Delivered
- REMEVi
- RxPepsDirect
- Semaglutide Online
- Superpower
- SurpassMD
- TeleCareSpot
- Trillium Meds
- Vita Bella
- Vytora Health
- YourHealthRx
Also consider: 331 providers with undisclosed state coverage
These providers offer GLP-1 weight loss service (verified on their own websites) but do not publish a complete state-availability list publicly — their intake flow determines eligibility. We have not independently confirmed Washington coverage for the providers below. Start the signup intake to check whether they serve your area before proceeding.
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Direct Meds
Best for: listed for disclosure only — see its FDA warning and BBB complaints first
Editorial score · methodology
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
Editorial score · methodology
Browse all 331 providers with undisclosed coverage on the District of Columbia page →
In-Person vs Telehealth in Washington
Patients in Washington have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to District of Columbia addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in District of Columbia varies by plan[4].
In-person weight-management clinics in Washington (116 in our directory)
From the NPI registry, cross-checked against obesity-medicine and bariatric taxonomy codes — mostly endocrinology, diabetes & metabolism.
- Abbas Motazedi — Endocrinology, Diabetes & Metabolism, 1160 Varnum St NE
- Abbas Motazedi, MD — Endocrinology, Diabetes & Metabolism, 1160 Varnum St NE Ste 111
- Adline Ghazi — Endocrinology, Diabetes & Metabolism, 2150 Pennsylvania Ave NW
- Ann Cowgill — Endocrinology, Diabetes & Metabolism, 50 Irving St NW
- Anteneh Zenebe — Endocrinology, Diabetes & Metabolism, 2041 Goergia Ave NW
- Cassandra Mcintyre — Endocrinology, Diabetes & Metabolism, 2100 Pennsylvania Ave NW
- Cecillia Tsao — Endocrinology, Diabetes & Metabolism, 128 M St NW
- Chelsey Baldwin — Endocrinology, Diabetes & Metabolism, 2300 M St NW
Cost of GLP-1 Medications in Washington
Brand-name Wegovy in Washington typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $199/month in District of Columbia, representing savings of more than $13,000 per year. For a full breakdown of every low-cost option, read our cheapest way to get GLP-1s without insurance guide. If you're deciding between the two paths, see our compounded vs. branded GLP-1 decision guide.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Get Washington Price Alerts
Be the first to know about new GLP-1 providers and price changes in Washington.
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.CDC BRFSS — Adult Obesity Prevalence Maps by State (Behavioral Risk Factor Surveillance System)— Centers for Disease Control and Prevention.
- 3.CDC — State Obesity Rankings and Adult Obesity Facts— Centers for Disease Control and Prevention.
- 4.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 5.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.